Additional studies have shown similar pro-tumorigenic alterations of the TME by STAT3 activation and the notable antitumor effects of STAT3 inhibition in a variety of cancers (for a comprehensive review on IL-6/JAK/STAT3 signaling in cancer, see Johnson et al. [43]). Here, STAT3 is linked to cancer.